Diabetes Complications 29 , 670674 (2015)
Next up: Im even experimenting with much lower doses than what we have in our current program, because I want to see the effects of that. BUT IS IT SAFE LONG-TERM
Marlet IR, lmestig JNE, Vilsbll T, Rungby J, Kruuse C (2018) Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies
The use of GLP-1RAs reduced independent nicotine use and nicotine cravings in animals, weight gain after nicotine cessation, cravings for it, abstinence and hyperphagia [84]
Due to the slowing of the gastrointestinal tract caused by GLP-1 receptor agonists, some patients may experience stomach pains or constipation
It is important to understand that the half-life indicates the time taken for the drug concentration to reduce by half